Skip to content
Thinking Narrowly About Antibiotics episode artwork

May 7, 2015 24 min

Thinking Narrowly About Antibiotics

from The Bio Report Hosted by Levine Media Group

With the mapping of the human microbiome, a new understanding is emerging of the complex relationship between the microorganisms that live in the human gut, skin, and elsewhere on the body, and the role they play both in disease and in maintaining health. Along with growing concerns about drug resistant bacteria, this is giving rise to opportunities for narrow spectrum antibiotics. We spoke to David Martin, founder and CEO of AvidBiotics, about the problems of antibiotic resistance, the benefits narrow spectrum therapies offer, and how the sequencing of the microbiome is leading to new approaches to not only treat infectious diseases, but other diseases not traditional thought of as being driven by microorganisms.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Thinking Narrowly About Antibiotics

0:00 24:22

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of The Bio Report?

This episode is 24 minutes long.

When was this The Bio Report episode published?

This episode was published on May 7, 2015.

Can I download this The Bio Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.